A genetic synthetic dosage lethality (SDL) screen using CTF13 encoding a known kinetochore protein as the overexpressed reference gene identified two chromosome transmission fidelity (ctf) mutants, YCTF58 and YCTF26. These mutant strains carry independent alleles of a novel gene, which we have designated CTF19. In light of its potential role in kinetochore function, we have cloned and characterized the CTF19 gene in detail. CTF19 encodes a nonessential 369–amino acid protein. ctf19 mutant strains display a severe chromosome missegregation phenotype, are hypersensitive to benomyl, and accumulate at G2/M in cycling cells. CTF19 genetically interacts with kinetochore structural mutants and mitotic checkpoint mutants. In addition, ctf19 mutants show a defect in the ability of centromeres on minichromosomes to bind microtubules in an in vitro assay. In vivo cross-linking and chromatin immunoprecipitation demonstrates that Ctf19p specifically interacts with CEN DNA. Furthermore, Ctf19-HAp localizes to the nuclear face of the spindle pole body and genetically interacts with a spindle-associated protein. We propose that Ctf19p is part of a macromolecular kinetochore complex, which may func- tion as a link between the kinetochore and the mitotic spindle.
Skip Nav Destination
Article navigation
5 April 1999
Article|
April 05 1999
Ctf19p: A Novel Kinetochore Protein in Saccharomyces cerevisiae and a Potential Link between the Kinetochore and Mitotic Spindle
Katherine M. Hyland,
Katherine M. Hyland
*The Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics, Baltimore, Maryland 21205; ‡Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada; and §Carnegie Institute of Washington, Department of Embryology, Baltimore, Maryland 21210
Search for other works by this author on:
Jeffrey Kingsbury,
Jeffrey Kingsbury
*The Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics, Baltimore, Maryland 21205; ‡Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada; and §Carnegie Institute of Washington, Department of Embryology, Baltimore, Maryland 21210
Search for other works by this author on:
Doug Koshland,
Doug Koshland
*The Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics, Baltimore, Maryland 21205; ‡Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada; and §Carnegie Institute of Washington, Department of Embryology, Baltimore, Maryland 21210
Search for other works by this author on:
Philip Hieter
Philip Hieter
*The Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics, Baltimore, Maryland 21205; ‡Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada; and §Carnegie Institute of Washington, Department of Embryology, Baltimore, Maryland 21210
Search for other works by this author on:
Katherine M. Hyland
*The Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics, Baltimore, Maryland 21205; ‡Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada; and §Carnegie Institute of Washington, Department of Embryology, Baltimore, Maryland 21210
Jeffrey Kingsbury
*The Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics, Baltimore, Maryland 21205; ‡Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada; and §Carnegie Institute of Washington, Department of Embryology, Baltimore, Maryland 21210
Doug Koshland
*The Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics, Baltimore, Maryland 21205; ‡Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada; and §Carnegie Institute of Washington, Department of Embryology, Baltimore, Maryland 21210
Philip Hieter
*The Johns Hopkins University School of Medicine, Department of Molecular Biology and Genetics, Baltimore, Maryland 21205; ‡Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia V5Z 4H4, Canada; and §Carnegie Institute of Washington, Department of Embryology, Baltimore, Maryland 21210
Address correspondence to Philip Hieter, Centre for Molecular Medicine and Therapeutics, 980 West 28th Avenue, Vancouver, BC V5Z 4H4, Canada. Tel.: (604) 875-3826. Fax: (604) 875-3840. E-mail: [email protected]
Received:
November 24 1998
Revision Received:
February 16 1999
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1999
J Cell Biol (1999) 145 (1): 15–28.
Article history
Received:
November 24 1998
Revision Received:
February 16 1999
Citation
Katherine M. Hyland, Jeffrey Kingsbury, Doug Koshland, Philip Hieter; Ctf19p: A Novel Kinetochore Protein in Saccharomyces cerevisiae and a Potential Link between the Kinetochore and Mitotic Spindle . J Cell Biol 5 April 1999; 145 (1): 15–28. doi: https://doi.org/10.1083/jcb.145.1.15
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement